• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Temporary move to Collegeville restructuring Plymouth Meeting

Anonymous

Guest
This move is on hold and possibly off. Poor planning, Collegeville tennant backed out and poor second quarter for US business the reason.

CIMA line slightly down, but MAS division is doing particularly bad.
 




Just trying to get this straight. So the move out of Collegeville back to Plymouth is off because they can't a tenent to sub-let the 10 year lease (lol) and they also had a less than stellar Q2. Color me shocked :)
 




Not exactly, the tenant part is right, but apparently they think putting everyone in PM is going to be two tight, so a lot of the 200 bldg is moving to PM but those in the 400 building are stuck there for the time being.
 








"two tight"....isn't it "too tight"? I am so glad to be away from the entire IMS/SDI mess.

You and 100's of others. The most comical part is how they retained so many "stellar" SDI and IMS employees after the acquisition. Almost to a person it's everyone for themselves. Those that got packages really are the lucky ones.
 








I dont know how the employees can know what is going on when upper management doesnt have a clue. First let's all move to Collegeville while construction goes on in PM, then, oh, it will be too crowded in PM with our plans, so lets keep some people in Cville and move some others. Then, oh, we cant find a new tenant for the 200 building, so we have to vacate that. Does IMS actually know how to plan and execute? Doesnt seem so - tooo buraucratic - one hand doesnt know what the other one is doing and that will NEVER change. Thaty mentality starts from the top!